Kimberly-Clark Corporation
11/13/2024 | Press release | Distributed by Public on 11/13/2024 16:04
Management Change/Compensation Form 8 K
Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers
(d)On November 13, 2024, the Board of Directors (the "Board") of Kimberly-Clark Corporation (the "Corporation") elected Joseph Romanelli, 51, as an independent member of the Board, and also appointed him to the Board's Audit Committee, effective immediately. In connection with the appointment of Mr. Romanelli, the size of the Board will be increased from twelve to thirteen directors. Mr. Romanelli serves as President of Human Health International for Merck & Co., Inc., a leading biopharmaceutical company. Mr. Romanelli will participate in the outside director compensation programs described under "Director Compensation" in the Corporation's proxy statement filed with the Securities and Exchange Commission on March 11, 2024.
A copy of the news release announcing the election of Mr. Romanelli to the Board is attached as Exhibit 99.1.